Overview

Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion

Status:
RECRUITING

Trial end date:
2025-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the safety and efficacy of endovascular treatment with or without preceding intravenous Tenecteplase in patients with late-window (4.5-24 hours of symptom onset) acute ischemic stroke due to middle cerebral artery (MCA) M1 or M2 occlusion.

Phase:

PHASE3

Details

Lead Sponsor:

Beijing Tiantan Hospital

Collaborator:

Linyi People's Hospital

Treatments:

Tenecteplase